For many, the main point of investing in the stock market is to achieve spectacular returns. While not every stock performs well, when investors win, they can win big. For example, the Cogstate ...

Most readers would already know that Cogstate's (ASX:CGS) stock increased by 8.3% over the past three months. Given that the market rewards strong financials in the long-term, we wonder if that is the ...

Eisai Co., Ltd. and Cogstate, Ltd. announced that the companies have entered into a collaboration whereby Eisai has secured the global development rights and exclusive commercialization rights of all ...

PERTH, Australia – Neuroscience technology company Cogstate Ltd. and Japanese pharmaceutical company Eisai Co. Ltd. signed a deal under which Eisai will have global development rights and exclusive ...

Good morning, everyone. Welcome to Cogstate's Full Year Results for Financial Year '25. I am conscious that the ASX has not yet released our results. We did lodge with the ASX at 7:30 this morning. So ...

Clinical research and health tech companies Medidata and Cogstate are joining forces to speed up trials and improve outcomes measurement across diseases of the central nervous system, the partners ...

PERTH, Australia – Digital cognitive assessment technology company Cogstate Ltd. saw its stock skyrocket 60% on the heels of FDA accelerated approval of Biogen Inc./Eisai Co. Ltd.’s Alzheimer’s ...

Japanese pharma Eisai is boosting its 2019 pact with Australian medtech firm Cogstate and its cognitive function test. The original pact, penned last August, was a development and sales deal centered ...